Oncology

Oncology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
Home Gateways Oncology
81-100 of 232 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.123714.2
Research Article metrics
Revised
Identification of prognostic biomarkers of invasive ductal carcinoma by an integrated bioinformatics approach
[version 2; peer review: 1 approved, 1 approved with reservations]
Albeiro Marrugo-Padilla, Johana Márquez-Lázaro, Antistio Álviz-Amador
Peer Reviewers Xingxin Pan; Russell Hamilton
LATEST VERSION PUBLISHED 30 Oct 2023
https://doi.org/10.12688/f1000research.110362.2
Case Report metrics
Revised
Case Report: Incidental discovery of primary peritoneal psammocarcinoma
[version 2; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Imen Helal, Fatma Khanchel, Raja Jouini, Maissa Ben Thayer, Chaouki Mbarki, Hajer Bettaieb, Saber Rebii, Imen Ben Ismail, Ehsen Ben Brahim, Aschraf Chedli-Debbiche
Peer Reviewers Marouen Braham; Isao Otsuka; Fnu Sapna; Charif Khaled
LATEST VERSION PUBLISHED 16 Oct 2023
https://doi.org/10.12688/f1000research.138519.1
Study Protocol metrics AWAITING PEER REVIEW
A study protocol for clinico-pathological diagnosis of hematological malignancies in a tertiary care hospital in central India
[version 1; peer review: awaiting peer review]
Priya Chatterjee, Kishore Hiwale, Sunita Vagha, Snehlata Hingway
Peer Reviewers Invited
PUBLISHED 05 Oct 2023
https://doi.org/10.12688/f1000research.110356.2
Case Report metrics
Revised
Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab
[version 2; peer review: 2 approved]
Georgios Axiaris, Alexandros Ioannou, Marina Papoutsaki, Leonidas Marinos, Michael Liontos, Spyridon Michopoulos, Evanthia Zampeli
Peer Reviewers Giovanni Marasco; Sophie Vieujean
LATEST VERSION PUBLISHED 04 Oct 2023
https://doi.org/10.12688/f1000research.127368.2
Review metrics
Revised
Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers
[version 2; peer review: 2 approved, 1 approved with reservations]
Monica Charlotte Solomon, Chetana Chandrashekar, Spoorti Kulkarni, Nisha Shetty, Aditi Pandey
Peer Reviewers John W Barrett; Ajaz Bhat; Jiji George
LATEST VERSION PUBLISHED 04 Oct 2023
https://doi.org/10.12688/f1000research.134302.2
Research Article metrics
Revised
Immune system and tumor microenvironment in early-stage breast cancer: different mechanisms for early recurrence after mastectomy and chemotherapy on ductal and lobular types
[version 2; peer review: 2 approved]
Andreas Andrianto, I Ketut Sudiana, Desak Gede Agung Suprabawati, Hari Basuki Notobroto
Peer Reviewers Sumadi Lukman Anwar; Kristanto Yuli Yarso
LATEST VERSION PUBLISHED 29 Sep 2023
https://doi.org/10.12688/f1000research.125272.2
Research Article metrics
Revised
Circadian disruption does not alter tumorigenesis in a mouse model of lymphoma
[version 2; peer review: 2 approved]
Rebecca M Mello, Marie Pariollaud, Katja A Lamia
Peer Reviewers Chi Van Dang; Eric Zhang
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 28 Sep 2023
https://doi.org/10.12688/f1000research.126232.2
Research Article metrics
Revised
Oncofertility awareness among primary care physicians in India
[version 2; peer review: 2 approved, 1 approved with reservations, 1 not approved]
Prathima Tholeti, Shubhashree Uppangala, Rajesh Kumar Jayaram, Karthik S Udupa, Guruprasad Kalthur, Norah Spears, Teresa Woodruff, Satish K Adiga
Peer Reviewers Padma Rekha Jirge; Regina Barragan-Carrillo; Alex C. Varghese; Giuliano Bedoschi
  • Funder
  • ICMR
LATEST VERSION PUBLISHED 28 Sep 2023
https://doi.org/10.12688/f1000research.133438.2
Case Report metrics
Revised
Case Report: Atypical presentation of non-functional gonadotropinoma
[version 2; peer review: 2 approved]
Suresh Oommen, Sam Rice
Peer Reviewers Robinson George; Atul Kalhan
LATEST VERSION PUBLISHED 14 Sep 2023
https://doi.org/10.12688/f1000research.130928.2
Case Report metrics
Revised
Case Report: Tracheal infiltration with wheezing revealing Hodgkin's disease
[version 2; peer review: 2 approved]
Selsabil Daboussi, Asma Saidane, Samira Mhamdi, Nouha boubaker, Chaabane Mariem, Chiraz Aichaouia, Ghedira Hela, Fehmi Msadek, Moetemri Zied
Peer Reviewers Ruwaida Ben Musa; Jeffrey W Craig
LATEST VERSION PUBLISHED 11 Sep 2023
https://doi.org/10.12688/f1000research.130316.1
Research Article metrics
Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Israa Shihab, Amal Bouzid, Burcu Yener, Alaa Altaie, Poorna Manasa Bhamidimarri, Mouza Al Ameri, Riyad Bendardaf, Mawieh Hamad, Rifat Hamoudi
Peer Reviewers Aamir Ahmed; Wenbin Zhou; Claudia Lanari and Andrés Elia
  • Funders
  • Al-Jalila Foundation
  • ASPIRE Precision Medicine Research Institute Abu Dhabi
PUBLISHED 08 Sep 2023
https://doi.org/10.12688/f1000research.138794.1
Case Report metrics
Case Report: Pleural effusion in Wilms tumor – always malignant?
[version 1; peer review: 2 approved]
Keta Vagha, Patel Zeeshan Jameel, Jayant Vagha, Ashish R. Varma, Rupesh Rao
Peer Reviewers Marcello Della Corte and Erica Clemente; Keerti Swarnakar
PUBLISHED 30 Aug 2023
https://doi.org/10.12688/f1000research.122408.2
Research Article metrics
Revised
Methylene blue sentinel lymph node biopsy for breast cancer learning curve in the COVID-19 era: How many cases are enough?
[version 2; peer review: 2 approved]
Yohana Azhar, Birgitta M. Dewayani, Kiki Lukman
Peer Reviewers Dedy Hermansyah; Tony Mallett and Owen Ung
LATEST VERSION PUBLISHED 29 Aug 2023
https://doi.org/10.12688/f1000research.139277.1
Research Article metrics
Antioxidant and apoptotic activities of sitagliptin against hepatocellular carcinoma: An in vitro study
[version 1; peer review: 1 approved with reservations]
Ruqaya Alameen, Ahsan Bairam, Maryam Al-Haddad
Peer Reviewers Ke Su
PUBLISHED 10 Aug 2023
https://doi.org/10.12688/f1000research.132516.2
Study Protocol metrics
Revised
Immunoexpression of E-cadherin in oral potentially malignant disorders, oral squamous cell carcinoma and its correlation with clinicopathological parameters
[version 2; peer review: 1 approved, 1 not approved]
Padmashri Kalmegh, Alka Hande, Madhuri Gawande, Swati Patil, Archana Sonone, Aayushi Pakhale
Peer Reviewers Reetoja Nag; Sankar Jagadeeshan
LATEST VERSION PUBLISHED 28 Jul 2023
https://doi.org/10.12688/f1000research.138264.1
Research Article metrics
Racial disparities in major cardiovascular and cerebrovascular adverse events in breast cancer survivors: A nationwide analysis
[version 1; peer review: 2 approved with reservations]
Akhil Jain, Rupak Desai, Ibrahim Ahmed, Kingsley Amakye, Maharshi Raval, Sagar Patel, Kanishka Uttam Chandani, Vidit Majmundar, Siddharth Pravin Agrawal, Labdhi Sanghvi, Monika Garg, Darsh Patel, Mohammad Hamza, Raphael Bonita, Sunil Dhar
Peer Reviewers Zhengyi Deng; Amanda Leiter
PUBLISHED 26 Jul 2023
https://doi.org/10.12688/f1000research.138951.1
Study Protocol metrics
Evaluation of  premetastatic changes in lymph nodes(pN0) of oral tongue tumour: A prospective observational Study
[version 1; peer review: 2 approved]
Rajalakshmi Geetha, Subramania Iyer, Pavithran Keechilat, Gopalakrishna Iyer N, Krishna Kumar Thankappan, Smitha N V
Peer Reviewers Maya Ramesh; Pankaj Chaturvedi
  • Funder
  • Department of Health Research, India
PUBLISHED 26 Jul 2023
https://doi.org/10.12688/f1000research.133852.1
Research Article metrics
Synergistic effect of the combination of Chrysanthemum cinerariifolium (Trev.) and doxorubicin in inhibiting PI3K and Cyclin D in oral squamous cell carcinoma: in vitro study
[version 1; peer review: 1 approved with reservations]
Anik Listiyana, Yuanita Lely Rachmawati, Hani Susianti, Nurdiana Nurdiana, Hidayat Sujuti, Roihatul Mutiah, Agustina Tri Endharti
Peer Reviewers Laiping Zhong
  • Funder
  • Ministry of Religion of the Republic of Indonesia
PUBLISHED 25 Jul 2023
https://doi.org/10.12688/f1000research.134510.1
Study Protocol metrics AWAITING PEER REVIEW
Protocol for evaluation and correlation of CD44 immunoexpression in tumor tissue and surgical margins of oral squamous cell carcinoma with three-year survival: A retrospective study
[version 1; peer review: awaiting peer review]
Husna Tehzeeb, Madhuri Gawande, Alka Hande, Swati Patil, Archana Sonone, Aayushi Pakhale
Peer Reviewers Invited
PUBLISHED 03 Jul 2023
https://doi.org/10.12688/f1000research.55516.2
Case Report metrics
Revised
Case Report: Metachronous bilateral upper tract and bladder urothelial carcinoma: a long-term follow-up
[version 2; peer review: 1 approved, 2 approved with reservations]
Agus Rizal Ardy Hariandy Hamid, Fakhri Zuhdian Nasher, Meilania Saraswati, Sahat Matondang, Chaidir Arif Mochtar
Peer Reviewers Alcides Chaux; Mohamed Mohamed Elawdy; Katsuhiro Ito
LATEST VERSION PUBLISHED 26 Jun 2023
81-100 of 232 ARTICLES
Previous Next
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.